Detalhe da pesquisa
1.
Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials.
Cancer
; 124(8): 1760-1769, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370458
2.
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network.
Haematologica
; 108(11): 3148-3151, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021537
3.
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
Leukemia
; 38(1): 58-66, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935977
4.
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.
Blood Adv
; 7(7): 1279-1285, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322825
5.
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients.
Biomark Res
; 11(1): 31, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927800
6.
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol
; 40(14): 1574-1582, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157496
7.
Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials.
J Clin Oncol
; 39(12): 1339-1348, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33729825
8.
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors.
J Natl Cancer Inst
; 113(8): 989-996, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629114
9.
A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535).
Blood Adv
; 4(8): 1683-1689, 2020 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32330241
10.
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.
J Clin Oncol
; 38(19): 2122-2129, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369401
11.
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.
J Patient Rep Outcomes
; 4(1): 54, 2020 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32642992
12.
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.
Biomark Res
; 8: 29, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817791
13.
Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.
JCO Oncol Pract
; 16(6): e464-e475, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048933
14.
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
J Natl Cancer Inst
; 111(2): 210-213, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30371800
15.
Percutaneous muscle biopsy-induced tissue injury causes local endoplasmic reticulum stress.
Physiol Rep
; 6(8): e13679, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29687616
16.
Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials.
JAMA Netw Open
; 1(4): e181235, 2018 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30646114
17.
Diurnal Variation in PDK4 Expression Is Associated With Plasma Free Fatty Acid Availability in People.
J Clin Endocrinol Metab
; 103(3): 1068-1076, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29294006
18.
Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report.
Biopreserv Biobank
; 16(1): 42-52, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29172682
19.
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.
J Clin Oncol
; 36(4): 326-332, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29136387
20.
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612.
Leuk Lymphoma
; 64(2): 473-477, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517990